Live antipsychotics updates

Live antipsychotics news coverage of developments with the latest updates. Stay on top of latest antipsychotics news stories and find out what just happened, what is going on with antipsychotics. The latest real-time news updates and headlines on antipsychotics
Australian Children Require More Mental Health Medication Amid Pandemic
Research finds clozapine reduces insomnia in schizophrenia
US Incarcerated People’s Chronic Health May be Severely Undertreated: Data Analysis
UOW-led study confirms genetic link to depression and schizophrenia
5 Reasons Why Your Medicine May Be Making You Hotter This Summer
Health Care Utilization Examined in State Cannabis Legalization
AI Could Help Ensure Safer Prescribing for People with ID and Epilepsy
Old antipsychotic drugs may offer new option to treat Type 2 diabetes
Rise in Antipsychotic Prescriptions for Youth Alarming: Study
Mental Disorder Diagnoses May Impact Antipsychotic Clinical Studies
World Patient Safety Day 2022 – Pharmacists key to reducing medicine harm
HKUMed research team estimates over 30% elevated risk of breast cancer among antipsychotic users
Ethnic inequalities in mental and physical multimorbidity in women of reproductive age: data linkage cohort study
Harmful antipsychotics prescribing jumped 50 per cent in dementia care homes during pandemic
Scientists Reveal Genetic Architecture Underlying Alcohol, Cigarette Abuse
Researchers Find Two FDA-Approved Drugs that Curb Symptoms of Alzheimer’s Disease
Scientists find two FDA-approved drugs that curb symptoms of Alzheimer’s
Pfizer Reports Additional Data on PAXLOVID Supporting Upcoming New Drug Application Submission to U.S. FDA
When reality fails: What to know about psychosis
Researchers develop medication-free approach for behavioral changes in Alzheimer’s
Pfizer to Invest $120 Million to Produce Covid Oral Treatment in U.S
Good news, bad news on risky medication use in nursing homes
Hospices vary widely in prescribing “comfort kit” medications
Hospices vary widely in prescribing of “comfort kit” medications
Pfizer Shares Top-Line Results from Phase 2/3 EPIC-PEP Study of PAXLOVID for Post-Exposure Prophylactic Use
Study links Mental illness to increased death from cardiovascular disease
Why Are We So Ashamed of Mental Illness? This Psychiatrist Is Determined to End Stigma
PSA welcomes Government’s commitment to improve medicine safety in Aged Care
Widely used nausea drugs linked to heightened risk of stroke
Pfizer to Supply UNICEF up to 4 Million Treatment Courses of Novel Covid Oral Treatment for Low- and Middle-Income Countries
Statement on Inappropriate Use of Psychotropic Medicines to Manage Behaviours of People with Disability and Older People
Pharmacists can help resolve troubling aged care findings
HRW Submission to UN Committee on Rights of Persons with Disabilities in Ghana
Prescribing of psychiatric drugs to Australian kids on rise
AMA successfully lobbies against amendments to antipsychotics in aged care
Sleep deprivation increases serotonin 2a receptor response in brain
Nearly one in five patients with heart disease use mental health drugs
Prepare to beat heat
Aged care pharmacists needed to improve quality of life for aged care residents
Potential new approach for treatment of schizophrenia
Brain imaging techniques top poll of key milestones in century of neurology
Study finds excess use of non-emergency restraint among older psychiatric patients
Research reveals excess use of non-emergency restraint among older psychiatric patients
Sleep in children with autism
Robotic pet boosts mood, behavior and cognition in adults with dementia
Common antidepressant should no longer be used to treat people with dementia, study says
Schizophrenia diagnosis rises among Black nursing home residents following start of Medicare initiative
Targeting new drugs for schizophrenia